Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Moody's
MCO
5
Jefferies Financial
JEF
US Stock MarketDetailed Quotes
ABOS Acumen Pharmaceuticals
- 1.080
- +0.010+0.93%
Close May 2 16:00 ET
- 1.060
- -0.020-1.85%
Post 18:09 ET
65.42MMarket Cap-0.63P/E (TTM)
1.115High1.040Low125.66KVolume1.090Open1.070Pre Close134.53KTurnover0.38%Turnover RatioLossP/E (Static)60.57MShares3.92052wk High0.36P/B35.56MFloat Cap0.85552wk Low--Dividend TTM32.93MShs Float26.980Historical High--Div YieldTTM7.01%Amplitude0.855Historical Low1.070Avg Price1Lot Size
About Acumen Pharmaceuticals Company
Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. Klein, Grant A. Krafft, and Caleb Finch in 1996 and is headquartered in Newton, MA.
Company Profile
SymbolABOS
Company NameAcumen Pharmaceuticals
Listing DateJul 1, 2021
Issue Price16.00
Founded1996
CEOMr. Daniel O'Connell
MarketNASDAQ
Employees61
Fiscal Year Ends12-31
Address1210-1220 Washington Street,Suite 210
CityNewton
ProvinceMassachusetts
CountryUnited States of America
Zip Code02465
Phone1-617-344-4190
Websitehttp://www.acumenpharm.com
Company Executives
- Name
- Position
- Salary
- Daniel O'Connell
- Director and Chief Executive Officer
- 4.78M
- Amy Schacterle
- Chief Regulatory Officer and Head of Quality
- --
- William Matthew Zuga
- Principal Accounting Officer, Chief Financial Officer and Chief Business Officer
- 1.69M
- Russell Barton, M.S.
- Chief Operating Officer
- --
- Derek M. Meisner
- Chief Legal Officer
- --
- Dr. Jim Doherty, PhD
- President and Chief Development Officer
- 2.18M
- Dr. Eric Siemers, M.D.
- Chief Medical Officer
- --
- Sean Stalfort
- Chairman of the Board
- 130.27K
- Dr. Nathan B. Fountain, M.D.
- Independent Director
- 91.77K
- Dr. Laura Stoppel, PhD
- Independent Director
- 103.27K
- Dr. Kimberlee Cobleigh Drapkin, PhD
- Independent Director
- 107.77K
- Dr. Jeffrey L. Ives, PhD
- Independent Director
- 97.77K
- Dr. Derrell D. Porter, M.D.
- Independent Director
- 91.77K
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now